Generic name (INN) · Small Molecule
zervimesine
zervimesine is a generic name (inn) for Zervimesine, developed by Cognition Therapeutics, Inc..
- Status
- Phase 2 for Alzheimer's disease
- Mechanism
- σ2 receptor (TMEM97) Antagonist
- Developer
- Cognition Therapeutics, Inc.
Programs
- Zervimesine for Alzheimer's diseasePhase 2Active
- Zervimesine for Lewy body dementiaPhase 2Active
Also known as
- CT1812
- CT-1812
- CT 1812
- Elayta
- 1802632-22-9
- 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol